H-SER-PHE-LEU-LEU-ARG-ASN-PRO-OH manufacturers
|
| | H-SER-PHE-LEU-LEU-ARG-ASN-PRO-OH Basic information |
| Product Name: | H-SER-PHE-LEU-LEU-ARG-ASN-PRO-OH | | Synonyms: | SFLLRNP;SER-PHE-LEU-LEU-ARG-ASN-PRO;THROMBIN RECEPTOR (42-48) AGONIST, HUMAN;thrombinreceptorpeptidesfllrnp;Thrombin Receptor (42-48), human;H-SER-PHE-LEU-LEU-ARG-ASN-PRO-OH;Thrombin Receptor (1-7), human;Proteinase Activated Receptor 1 (1-7) (huMan), ThroMbin Receptor (1-7) (huMan), SFLLRNP, ThroMbin Receptor Activator Peptide 7, PAR-1 (1-7) (huMan), Coagulation Factor II Receptor (1-7) (huMan) | | CAS: | 145229-76-1 | | MF: | C39H63N11O10 | | MW: | 845.99 | | EINECS: | | | Product Categories: | peptide;proteins | | Mol File: | 145229-76-1.mol |  |
| | H-SER-PHE-LEU-LEU-ARG-ASN-PRO-OH Chemical Properties |
| storage temp. | -15°C | | form | Solid | | color | White to off-white |
| | H-SER-PHE-LEU-LEU-ARG-ASN-PRO-OH Usage And Synthesis |
| Uses | TRAP-7 is a thrombin receptor (PAR) activating peptide. TRAP-7 stimulates total inositol phosphate (IP) accumulation and phosphorylation of a specific endogenous substrate for activated PKC. TRAP-7 can be used in cardiovascular disease research[1]. | | References | [1] Webb ML, et al. Effects of thrombin receptor activating peptide on phosphoinositide hydrolysis and protein kinase C activation in cultured rat aortic smooth muscle cells: evidence for "tethered-ligand" activation of smooth muscle cell thrombin receptors. Biochem Pharmacol. 1993 Apr 22;45(8):1577-82. DOI:10.1016/0006-2952(93)90297-a |
| | H-SER-PHE-LEU-LEU-ARG-ASN-PRO-OH Preparation Products And Raw materials |
|